Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 39 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,801,000 | – | 67,800 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,104,278 | $54,837,000 | 4.96% |
| Cormorant Asset Management, LP | 883,800 | $23,032,000 | 1.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 190,000 | $4,951,000 | 0.76% |
| Perceptive Advisors | 854,940 | $22,280,000 | 0.60% |
| Artal Group S.A. | 400,000 | $10,424,000 | 0.42% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 207,089 | $5,397,000 | 0.18% |
| Vident Investment Advisory, LLC | 64,571 | $1,683,000 | 0.15% |
| Tuttle Capital Management, LLC | 11,618 | $309,000 | 0.08% |
| Baker Brothers Advisors | 102,800 | $2,679,000 | 0.02% |
| AXA S.A. | 311,010 | $8,104,000 | 0.02% |